Brief: Hester Biosciences Acquires Technology For Production Of Classical Swine Fever & Sheep Pox Vaccines
08/04/2021 07:45
April 8 (Reuters) - Hester Biosciences Ltd HEST.NS :
* ACQUIRES TECHNOLOGY FROM ICAR-IVRI FOR PRODUCTION &
COMMERCIALIZATION OF CLASSICAL SWINE FEVER VACCINE & SHEEP POX
VACCINE
* TARGETED TO LAUNCH BOTH VACCINES COMMERCIALLY IN ABOUT 8
MONTHS
Source text for Eikon: ID:nBSE7BfHsH
Further company coverage: HEST.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hester Biosciences
See all newsIndia's Hester Biosciences jumps on quarterly profit rise
Brief: Hester Biosciences March-Quarter Consol Net Profit 159.8 Million Rupees
India's Hester Biosciences gains on plan to sell stake in Texas Lifesciences
Brief: Hester Biosciences Approves Divestment Of 43.81% Equity In Texas Lifesciences
Brief: Hester Biosciences Re-Appoints Rajiv Gandhi As CEO & MD